TFE3 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions: Together, by taking a chemogenetic approach, we have demonstrated the feasibility of manipulating the dissolution of TFE3 oncofusion condensates to effectively curtail tRCC cell growth both in vitro and in vivo.